Sign in

CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222372868
Phone
(630) 874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 4 Open-market buy Interim PEO and Interim COO bought 5,000 shares at $6.88 ($34,395)
  2. 4 Open-market sale VP and General Counsel sold 1,614 shares at $6.81 ($10,983)
  3. 4 Open-market sale SVP, R&D Program Management sold 25,000 shares at $6.78 ($169,500)
  4. 4 Grant or award VP, Controller and PAO acquired 8,000 shares (grant or award)
  5. 4 Open-market sale Director sold 2,000 shares at $6.92 ($13,842)
  6. 4 Grant or award Director acquired 13,737 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 3/A Insider 3/A
  9. 4/A Derivatives Options or other derivatives
  10. 4 Grant or award VP, Clinical Development acquired 4,000 shares (grant or award)
  11. 4 Grant or award SVP, R&D Program Management acquired 10,000 shares (grant or award)
  12. 4 Grant or award VP and General Counsel acquired 10,000 shares (grant or award)
  13. 4 Grant or award VP, Research acquired 3,500 shares (grant or award)
  14. 4 Grant or award Executive VP, COO, PEO, CFO acquired 45,000 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 28 · 560 filings